ISSN: ISSN 2472-016X



当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得


Advancements in Chemotherapeutic Drug Delivery Carriers in Orthopedic Oncology

Sinus Berlin

Orthopedic oncology faces unique challenges in delivering chemotherapeutic drugs effectively while minimizing
systemic toxicity. Recent advancements in drug delivery systems have propelled the development of innovative carriers
designed to enhance targeted delivery to musculoskeletal tumors. This abstract provides a concise overview of these
advancements, focusing on key modalities such as nanoparticles, polymeric micelles, liposomes, hydrogels, and
magnetic drug delivery. These carriers offer the potential for precise and personalized treatment strategies, allowing
for increased drug bioavailability at the tumor site while minimizing adverse effects on healthy tissues. The abstract
underscores the transformative impact of these advancements on the future of orthopedic oncology, emphasizing the
potential for improved therapeutic outcomes and reduced treatment-related morbidity.